BE773484A - Procede pour preparer des arylpyrimidines, qui sont des inhibiteurs de l'agglutination des plaquettes sanguines et des bronchodilatateurs - Google Patents

Procede pour preparer des arylpyrimidines, qui sont des inhibiteurs de l'agglutination des plaquettes sanguines et des bronchodilatateurs

Info

Publication number
BE773484A
BE773484A BE773484A BE773484A BE773484A BE 773484 A BE773484 A BE 773484A BE 773484 A BE773484 A BE 773484A BE 773484 A BE773484 A BE 773484A BE 773484 A BE773484 A BE 773484A
Authority
BE
Belgium
Prior art keywords
arylpyrimidines
bronchodilators
agglutination
inhibitors
preparing
Prior art date
Application number
BE773484A
Other languages
English (en)
French (fr)
Inventor
G G De Angelis
H-J E Hess
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE773484A publication Critical patent/BE773484A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BE773484A 1970-10-05 1971-10-05 Procede pour preparer des arylpyrimidines, qui sont des inhibiteurs de l'agglutination des plaquettes sanguines et des bronchodilatateurs BE773484A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7821670A 1970-10-05 1970-10-05

Publications (1)

Publication Number Publication Date
BE773484A true BE773484A (fr) 1972-04-05

Family

ID=22142671

Family Applications (1)

Application Number Title Priority Date Filing Date
BE773484A BE773484A (fr) 1970-10-05 1971-10-05 Procede pour preparer des arylpyrimidines, qui sont des inhibiteurs de l'agglutination des plaquettes sanguines et des bronchodilatateurs

Country Status (16)

Country Link
US (1) US3707560A (cs)
JP (2) JPS5648511B1 (cs)
AT (4) AT314540B (cs)
AU (1) AU465734B2 (cs)
BE (1) BE773484A (cs)
CA (1) CA988519A (cs)
CH (4) CH554875A (cs)
DE (2) DE2165962C2 (cs)
DK (1) DK131858C (cs)
ES (4) ES395676A1 (cs)
FI (1) FI55502C (cs)
FR (1) FR2110227B1 (cs)
GB (2) GB1373535A (cs)
NL (1) NL168511C (cs)
SE (2) SE390304B (cs)
ZA (1) ZA716615B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3895112A (en) * 1970-10-05 1975-07-15 Pfizer Arylpyrimidines in the relaxation of smooth muscle
US3908012A (en) * 1970-10-05 1975-09-23 Pfizer Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators
US3859288A (en) * 1970-10-05 1975-01-07 Pfizer Arylpyrimidines - inhibitors of platelet aggregation and bronchodilators
US3835132A (en) * 1972-02-01 1974-09-10 Shell Oil Co Morpholino-piperazinyl pyrimidines
US3950525A (en) * 1973-06-19 1976-04-13 Pfizer Inc. Relaxation of smooth muscle in a mammal
DE2343419A1 (de) * 1973-08-29 1975-03-13 Gruenenthal Chemie Verfahren zur herstellung von pyrimidinderivaten
US4725600A (en) * 1984-07-13 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent
JPH0625157B2 (ja) * 1988-01-29 1994-04-06 宇部興産株式会社 ４―ヒドロキシピリミジン類の製造方法
US4935516A (en) * 1988-01-29 1990-06-19 Ube Industries, Ltd. Process for preparing 4-hydroxypyrimidine
DE3825647A1 (de) * 1988-07-28 1990-02-01 Geyer Gmbh & Co Christian Vorrichtung zur befestigung eines elektrischen schaltgeraetes
DE3905364A1 (de) * 1989-02-22 1990-08-23 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
JP2003505384A (ja) 1999-07-15 2003-02-12 ファーマコピーア，インコーポレーティッド ブラジキニンｂ１受容体アンタゴニスト
US7731985B2 (en) * 2002-03-15 2010-06-08 Ciba Specialty Chemicals Corporation 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
EP1542692B1 (en) * 2002-05-22 2011-01-05 Amgen Inc. Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain
MXPA05010496A (es) * 2003-03-28 2005-11-16 Pharmacia & Upjohn Co Llc Moduladores alostericos positivos del receptor de acetilcolina nicotinico.
EP1877400A1 (en) * 2005-04-15 2008-01-16 Amgen, Inc Vanilloid receptor ligands and their use in treatments
JP2009164373A (ja) * 2008-01-08 2009-07-23 Toshiba Corp 半導体装置
KR20120131161A (ko) * 2010-01-25 2012-12-04 씨에이치디아이 파운데이션, 인코포레이티드 특정 키뉴레닌-3-모노옥시게나제 억제제, 그의 제약 조성물 및 사용 방법
CN106518845B (zh) 2011-08-30 2019-09-13 Chdi基金会股份有限公司 犬尿氨酸-3-单加氧酶抑制剂、药物组合物及其使用方法
CA2844521A1 (en) 2011-08-30 2013-03-07 Chdi Foundation, Inc. Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
ES2747633T3 (es) 2014-07-17 2020-03-11 Chdi Foundation Inc Combinación de inhibidor KMO 6-(3-cloro-4-ciclopropoxifenilo)pirimidina-4-ácido carboxílico con un agente antiviral para el tratamiento de trastornos neurológicos relacionados con VIH

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3047462A (en) * 1959-03-06 1962-07-31 Lab Jacques Logeais Soc D Expl Quinazolone anti-inflammatory composition

Also Published As

Publication number Publication date
US3707560A (en) 1972-12-26
SE7410488L (cs) 1974-08-16
DK131858B (da) 1975-09-15
DE2149249C3 (de) 1975-07-03
ES420209A1 (es) 1976-06-01
ES420211A1 (es) 1976-03-16
AT317229B (de) 1974-08-26
CA988519A (en) 1976-05-04
GB1373535A (en) 1974-11-13
NL7113670A (cs) 1972-04-07
SE390304B (sv) 1976-12-13
DE2149249B2 (de) 1974-11-07
DK131858C (da) 1976-02-16
CH554875A (fr) 1974-10-15
NL168511B (nl) 1981-11-16
CH542218A (fr) 1973-11-15
CH554876A (fr) 1974-10-15
JPS5648511B1 (cs) 1981-11-16
NL168511C (nl) 1982-04-16
DE2149249A1 (de) 1972-04-13
DE2165962A1 (de) 1972-08-31
AT316563B (de) 1974-06-15
FI55502B (fi) 1979-04-30
AT315856B (de) 1974-05-15
ZA716615B (en) 1972-06-28
JPS578107B2 (cs) 1982-02-15
FR2110227A1 (cs) 1972-06-02
FI55502C (fi) 1979-08-10
AU465734B2 (en) 1975-10-09
ES420210A1 (es) 1976-06-01
JPS5636468A (en) 1981-04-09
ES395676A1 (es) 1974-10-16
FR2110227B1 (cs) 1975-02-07
DE2165962C2 (de) 1982-05-13
GB1373536A (en) 1974-11-13
CH554346A (fr) 1974-09-30
SE385885B (sv) 1976-07-26
AU3425971A (en) 1973-04-12
AT314540B (de) 1974-04-10

Similar Documents

Publication Publication Date Title
BE773484A (fr) Procede pour preparer des arylpyrimidines, qui sont des inhibiteurs de l'agglutination des plaquettes sanguines et des bronchodilatateurs
BE779203A (fr) 2-hydrocarbyldithio-5-mercapto-1, 3, 4, -thiadiazoles et procede pour les preparer,
RO64158A (fr) Procede pour la preparation des phenylimidazolylalcanyles
RO67478A (ro) Procedeu pentru prepararea unor pleuromutiline
RO63376A (fr) Procede pour la preparation des diols
BE807706A (fr) Procede pour la preparation de cycloalcanones et/ou cycloalcanols
BE780013A (fr) Procede pour la propagation des rhizomes de pommiers nains
RO62694A (fr) Procede pour la preparation des 3-methylencephalosporines
RO70438A (ro) Procedeu pentru prepararea unor pirol-2-carboxamide substituite
RO61063A (fr) Procede pour la preparation des naphtyle alkylamines
RO63012A (fr) Procede pour la preparation des n-(furrylmethyle)-morphinanes
BE780082A (fr) Composes nouveaux de traitement et de prevention de la coccidiose, et procede pour les preparer
RO64269A (fr) Procede pour la preparation des izoxazole-(5,4-d)-pirymidines
BE766734A (fr) Procede pour la preparation d'amines
RO68378A (ro) Procedeu pentru prepararea unor n-benzhidril-n'-p-hidroxibenzil-piperazine
RO63031A (fr) Procede pour la preparation des pyrido-(3,2-d)-pyrimidi
RO62267A (fr) Procede pour la preparation des 1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropanes
BE763637A (fr) Procede pour la preparation de thiourees symetriques 1,3- disubstitueesaliphatiques et cycloaliphatiques
BE750263A (fr) Procede pour la preparation d'amino-cetones
CH549557A (fr) Procede pour la preparation des thioethers de la cysteine.
RO63003A (fr) Procede pour la preparation des n-(heteroarylmethyl)-deltaen hauf-desoxynomorphines et des norcodeines
BE759840A (fr) 2,9-dioxatricyclo-(4,3,1,0,3,7)-decanes et procede pour les preparer
BE773500A (fr) Procede de preparation d'alcoxyacetaldehydes et d'acyloxyacetaldehydes
RO63938A (fr) Procede pour la preparation des anilides
BE761685A (fr) Procede pour la preparation d'isoxazolylethyl-tetrahydropyranols

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: PFIZER INC.

Effective date: 19841005